-+ 0.00%
-+ 0.00%
-+ 0.00%

SYNAPTOGENIX INC: DELIVERY OF A TERMINATION NOTICE PURSUANT TO ITS AGREEMENT TO CONDUCT A PHASE 1 TRIAL OF BRYOSTATIN-1 IN MULTIPLE SCLEROSIS

Reuters·12/20/2024 14:24:57

Please log in to view news